Group One Trading’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-7,900
| Closed | -$536K | – | 5962 |
|
|
2019
Q3 | $536K | Buy |
+7,900
| New | +$543K | ﹤0.01% | 2277 |
|
|
2018
Q4 | – | Sell |
-200
| Closed | -$14K | – | 5751 |
|
|
2018
Q3 | $14K | Hold |
200
| – | – | ﹤0.01% | 4554 |
|
|
2018
Q2 | $10K | Sell |
200
-800
| -80% | -$31.7K | ﹤0.01% | 4636 |
|
|
2018
Q1 | $31K | Hold |
1,000
| – | – | ﹤0.01% | 3903 |
|
|
2017
Q4 | $34K | Buy |
+1,000
| New | +$31.9K | ﹤0.01% | 3931 |
|
|
2016
Q1 | – | Sell |
-4,000
| Closed | -$141K | – | 5200 |
|
|
2015
Q4 | $141K | Buy |
4,000
+3,300
| +471% | +$88.4K | ﹤0.01% | 2759 |
|
|
2015
Q3 | $15K | Hold |
700
| – | – | ﹤0.01% | 4168 |
|
|
2015
Q2 | $19K | Buy |
+700
| New | +$19.7K | ﹤0.01% | 4058 |
|
|
2014
Q4 | – | Sell |
-100
| Closed | -$3K | – | 5481 |
|
|
2014
Q3 | $3K | Sell |
100
-200
| -67% | -$5.58K | ﹤0.01% | 4875 |
|
|
2014
Q2 | $8K | Sell |
300
-3,500
| -92% | -$93.2K | ﹤0.01% | 4616 |
|
|
2014
Q1 | $100K | Buy |
3,800
+3,600
| +1,800% | +$103K | ﹤0.01% | 3089 |
|
|
2013
Q4 | $6K | Sell |
200
-2,500
| -93% | -$79.3K | ﹤0.01% | 4812 |
|
|
2013
Q3 | $83K | Buy |
2,700
+1,900
| +238% | +$63.5K | ﹤0.01% | 3177 |
|
|
2013
Q2 | $25K | Buy |
+800
| New | +$26.3K | ﹤0.01% | 3950 |
|
Group One Trading's GHDX Position: Q3 2019 in Review
Group One Trading sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 2,131 shares — an estimated $146K sold.
Group One Trading first reported a position in GHDX in Q2 2013 and held it in 11 quarters. The position peaked at $385K in Q1 2015. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.
- Group One Trading reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
- Group One Trading sold 2,131 Genomic Health, Inc. shares in Q3 2019, an estimated $146K.
- Group One Trading first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 11 quarters.
- Group One Trading's Genomic Health, Inc. position peaked at $385K in Q1 2015.
- 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.
Based on Group One Trading's 13F filing for Q3 2019, filed 12 Nov 2019.